Oxcarbazepine for refractory epilepsy: systematic review of the literature
CONTEXT AND OBJECTIVE: It has been estimated that 50 million people worldwide suffer from epilepsy and around 30% will not achieve adequate control over the disease. The aim was to evaluate the effectiveness of oxcarbazepine for refractory partial or generalized epilepsy. METHODS: Systematic review. A search was conducted in the PubMed, Lilacs, EMBASE and CENTRAL databases. Studies were analyzed using the Cochrane Collaboration methodology. RESULTS: Four randomized clinical trials of medium to poor methodological quality were included. Among the adult patients, the chances that they would obtain a 50% reduction in seizure frequency were greater after using oxcarbazepine at doses of 600 mg (relative risk, RR 2.11; 95% confidence interval, CI 1.32 to 3.35), 1,200 mg (RR 3.24; 95% CI 2.11 to 4.98) and 2,400 mg (RR 3.83; 95% CI 2.59 to 5.97). Among the children, the response in the group using oxcarbazepine was also greater (RR 2.11; 95% CI 1.32 to 3.35). The oxcarbazepine doses of 1,200 mg (RR 17.59; 95% CI 2.37 to 130.35) and 2,400 mg (RR 25.41; 95% CI 6.26 to 103.10) were effective for keeping patients probably free from seizures, but the dose of 600 mg was not. There was no significant difference between oxcarbazepine and carbamazepine for controlling the crises. CONCLUSIONS: There is moderate evidence indicating that oxcarbazepine is effective as an alternative treatment for partial or generalized epilepsy in children and adults who were refractory to previous treatment
Main Authors: | Saconato,Humberto, Prado,Gilmar Fernandes do, Puga,Maria Eduarda dos Santos, Atallah,Álvaro Nagib |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Associação Paulista de Medicina - APM
2009
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802009000300008 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systematic reviews of medical literature and metanalyses
by: Atallah,Álvaro Nagib
Published: (1996) -
Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews
by: Melnik,Tamara, et al.
Published: (2010) -
Cannabidiol for the treatment of refractory epilepsy in children: a critical review of the literature
by: Moreira,Gabriela Araujo, et al.
Published: (2023) -
Oral drugs for hypertensive urgencies: systematic review and meta-analysis
by: Souza,Luciana Mendes, et al.
Published: (2009) -
Oxcarbazepine and spasticity: further observations
by: Bittencourt,Paulo Rogério M.
Published: (1988)